Roundtable Discussion: Platelet Function Testing - Efficacy and Safety of Antiplatelet Agents

Published: 09 July 2015

  • Views:

    Views Icon 165
  • Likes:

    Heart Icon 0

Overview

Full programme

  • Views:

    Views Icon 165
  • Likes:

    Heart Icon 0

Overview

During ESC 2013 (NL), Radcliffe Cardiology, in association with the Interventional Cardiology Review journal, filmed a roundtable discussion entitled 'Balancing the Efficacy and Safety of Antiplatelet Agents'.

The discussion was moderated by Robert Storey, (Sheffield, UK). He was joined by expert group of physicians including Jean-Philippe Collet, (Paris, FR)Antonio Colombo, (Milan, IT), Jeff Daheln, (Accumetrics, US), Guillaume Taylor, (Paris, FR) and Stavros Spiliopoulos, (Rion, GR).

The meeting comprised of four multidisciplinary panel discussions on a range of topical issues related to antiplatelet therapy and platelet function testing

Target Audience

This educational activity is intended for an international audience, specifically:

  • Interventional Cardiologists
  • Interventional Radiologists
  • Aligned healthcare professional involved with antiplatelet therapy

Key Learning Objectives

Designed to support the continuous education of practicing physicians, this roundtable shares leading opinion and addresses the following questions and key educational objectives:

  • Increase physician awareness of the multidisciplinary role of antiplatelet therapy
  • Increase understanding of the role of platelet function testing in high-risk PCI
  • Explain the emerging role of PFT in PAD
  • Assess the role of antiplatelets in neuro-endovascular procedures

Series overview

Part 1

SESSION 1

1 session

  • SESSION 1: THE CLINICAL VALUE OF PLATELET RE-ACTIVITY TESTING – AN INTRODUCTION

    Watch now

Part 2

SESSION 2

1 session

  • SESSION 2: THE ROLE OF ANTIPLATELET THERAPIES IN NEURO-ENDOVASCULAR PROCEDURES

    Watch now

Part 3

SESSION 3

1 session

  • SESSION 3: PLATELET REACTIVITY TESTING – TREATMENT OPTIONS FOR HIGH-RISK PCI PATIENTS

    Watch now

Part 4

SESSION 4

1 session

  • SESSION 4: A REVIEW OF THE PROCEDURES IN PERIPHERAL INTERVENTION THAT REQUIRE ANTIPLATELET THERAPY

    Watch now

Part 5

SESSION 5

1 session

  • SESSION 5: BALANCING THE EFFICIENCY AND SAFETY OF ANTIPLATELET AGENTS – A CROSS-THERAPY DISCUSSION

    Watch now

Faculty biographies